Instead, companies have focused on specific, diagnosable conditions related to ageing such as Alzheimers, osteoporosis, or sarcopenia to get regulatory approval
Without mechanical stimulus, muscle loss becomes more likely during calorie reduction
At 1 mg/mL or 2.5 mg/mL concentrations used by other providers the same draw delivers a fraction of that amount
This person has modest weight loss goals achievable through lifestyle modifications but wants additional support beyond diet and exercise alone
If this same drug also receives FDA approval to treat diabetes or reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight, then it would be considered a Part D drug for those specific uses only Nothing has changed about the underlying rules, but as noted above, some GLP-1 medications have since received FDA approval to treat other medical conditions
